Optimized ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers (MiSeq)
收藏NIAID Data Ecosystem2026-05-25 收录
官方服务：
资源简介：
ARID1A is highly mutated in clear cell and endometrioid carcinomas of the ovary and endometrium. We have optimised and validated ARID1A IHC as a useful biomarker to stratify gynaecological cancer patients with 100% accuracy.
创建时间：
2018-05-01
